- Home
- usa massachusetts
- Companies
Refine by
Industries served
- Medical / Health Care
- Agriculture
- Energy
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Water and Wastewater
- Environmental
- Manufacturing, Other
- Health and Safety
- Electronics and Computers
- Aerospace & Air Transport
- Oil, Gas & Refineries
- Banking & Finance / Insurance / Legal
- Plastics & Resins
- Communications / Telecom / Datacom
- Food and Beverage
- Construction & Construction Materials
- Mining
- Automobile & Ground Transport
- Defense
- Commercial
- Logistics
- Metal
- Paint
- Waste and Recycling
- Air and Climate
- University / Academia / Research
Medical Industry Technology Serving In Massachusetts
391 companies found
Technologybased inSouth San Francisco, CALIFORNIA (USA)
Neurona Therapeutics is driven by rigorous scientific discovery and focused on developing breakthrough treatments for neurological disorders. Neurona Therapeutics is a privately-held, clinical-stage biotherapeutics company focused on discovering and ...
Technologybased inGrand Island, NEW YORK (USA)
Founded in 1986 in Grand Island, New York, GP:50 is an ISO9001 certified leading designer and manufacturer of reliable and accurate pressure sensing. A unique core competency of the company is its capability to customize specialty pressure sensors ...
Model 7730 dual cryogenic pressure temperature transducer series from GP:50 provides pressure and temperature measurement in one device down to -320 °F (-196 °C). The remote mounted electronics offers a high level output of 4-20 mA, 0 to 5 ...
Technologybased inGaithersburg, MASSACHUSETTS (USA)
In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly ...
ImmTOR has significant potential to mitigate unwanted immune responses and induce AAV-specific tolerance to enable redosing of gene therapies. ImmTOR has the potential to administer multiple low doses to achieve therapeutic benefit without ...
Technologybased inWildau, GERMANY
Behind BIOMES is a team of passionate and experienced scientists. We built our company on the basis of years of research work with the goal of making cutting-edge technologies accessible to everyone. Our vision: We want to help people live healthier ...
Technologybased inReno, NEVADA (USA)
DxDiscovery is a biotechnology Research & Development firm. The corporate goal is to develop quality, high-affinity antibodies to microbial antigens. These antibodies are incorporated into rapid POC diagnostics, or they may be developed as ...
An essential aspect of immunoassay development is the identification of target antigens that are shed or secreted during infection that can be used as targets for diagnosis. In an attempt to identify circulating bacterial and fungal antigens that ...
Technologybased inLexington, MASSACHUSETTS (USA)
At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster. We come to work every day to solve critical needs in healthcare diagnostics with innovative solutions built ...
Detection of biothreat pathogens in 3-5 hours— direct from whole blood: The T2Biothreat® Panel, which runs on the T2Dx® Instrument, is a direct-from-blood test panel that provides results in 3-5 hours and simultaneously detects six ...
Technologybased inSydney, AUSTRALIA
Four years ago, our mother Helene was diagnosed with severe auto-immune neuropathy. At the time we were juggling study and work, and we suddenly found ourselves facing the constant worry that mum might fall when we weren’t there with her. When Mum ...
Technologybased inEspoo, FINLAND
Software Point is the leading Laboratory Information Management System (LIMS) company in Northern Europe. We have delivered innovative LIMS and biobank solutions to more than 500 big and small laboratories, in public and private sectors, in ...
Technologybased inToronto, ONTARIO (CANADA)
Theralase was one of the first companies in North America to bring CLT to patients and the first company in the world to bring personalized ACT to patients individual tissue characteristics. With our multi-discipline experience in physics, ...
The Theralase TLC-2000 CLT is a medical device consisting of a hand-held multiple laser probe (5 x 905 nanometer (“nm”) Near Infra Red (“NIR”) super-pulsed laser diodes, providing up to 200 milliWatts (“mW”) ...
Technologybased inCambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
VOR33 is our lead eHSC product candidate designed to replace the standard of care in transplant settings. Once the VOR33 cells have engrafted, we believe that patients can be treated with anti-CD33 therapies, such as Mylotarg or VCAR33, with limited ...
Technologybased inFraser, MICHIGAN (USA)
Since 1969, Healthmark Industries Company, Inc. has developed and marketed innovative solutions to aid healthcare facilities in their delivery of surgical instruments and other life saving medical devices to patients. These solutions include: ...
Cart washers are important tools in the overall effort to reduce cross contamination. Often they are used to clean not just surgical case carts, but also basins, instrument trays, wheel chairs and other supply and patient transport equipment. The ...
Technologybased inProvidence, RHODE ISLAND (USA)
A spinout of Oxford University, founded by a global team of experienced entrepreneurs, technologists, and neuroscientists, ni2o is continuing the work started by MIT’s Mind Machine Project – developing a revolutionary brain-computer interface (BCI) ...
Technologybased inJohannesburg, SOUTH AFRICA
Since 1970, CO2 emissions have increased by about 90%, with emissions from fossil fuel combustion and industrial processes contributing about 78% of the total greenhouse gas emissions increase from 1970 to 2011. This process causes global warming, ...
To accelerate feedstock optimisation we have built the Distributed BioMaterials Mini-Consortium [DBMC's] to contribute towards the development of performance advantaged bioproducts by leveraging our marketplace. ...
Technologybased inChesterfield, MISSOURI (USA)
Partek bioinformatics software delivers powerful statistical and visualization tools in an easy-to-use interface. Researchers of all skill levels are empowered to explore genomic data quicker and easier than ever before. We turn data into discovery. ...
If you don’t have the time or resources to process and analyze your genomic data, Partek Discovery Services can help. We have the expertise, experience, and computing power to analyze RNA, DNA, and gene regulation studies quickly and ...
Technologybased inLausanne, SWITZERLAND
Amazentis is an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life. We employ rigorous science to pioneer the discovery and clinical development ...
Technologybased inBethesda, MARYLAND (USA)
Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...
Mucopolysaccharidosis type 1 (MPS 1) is a rare lysosomal storage disease that is caused by mutations in IDUA, the gene that encodes the alpha-L-iduronidase (IDUA) enzyme. These mutations cause the misfolding and dysfunction of IDUA, which leads to ...
Technologybased inDubendorf, SWITZERLAND
VunaNexus uses a patented technology to transform human and livestock urine into two valuable products: a fertiliser free of all dangerous pollutants and water that can be reused, this while drastically reducing ammonia emissions and water ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
MT-303 represents the first candidate in a new therapeutic modality targeting hepatocellular carcinoma (HCC). Liver cancer is a prevalent and challenging cancer with over 850,000 new cases diagnosed globally each year, and the third leading cause of ...
Technologybased inMonterey, CALIFORNIA (USA)
Vybion has pioneered vectorized Intrabodies, the delivery of functional antibody fragments in the scFv format to cells using Adeno associated virus (AAV). The Company has Orphan Drug Designation from the FDA for INT41 to treat Huntington’s disease a ...
INT41 has received Orphan Drug Designation from the FDA for Huntington’s disease. IND enabling studies for INT41 Gene Therapy for Huntington’s disease are in place following a preIND meeting with the FDA in in February 2022 in response ...
Technologybased inSuwon, SOUTH KOREA
Onegene Biotechnology develops transformative therapeutics for the chronic and complex diseases. Our UniStac platform allows rationale-based design of multispecific drug in true plug-and-play ...
OGB23501 is a first-in-class tri-specific tumor microenvironment (TME) immune activator, which simultaneously targets PD-1, CTLA-4, and VEGF. We aim to develop it as a potential backbone therapy for melanoma, NSCLC, HCC, and renal ...